Fundraising Fox

Healthtech Startups

17,200 companies tagged Healthtech, with their investors and founders.

Switch Healthcare

Switch Healthcare is a Health Value Organization (HVO) that aims to help employers improve healthcare outcomes and control costs for their companies and employees, positioning itself as an alternative to conventional healthcare vendors and benefit advisors. It targets company leaders such as CEOs and CFOs and references an Alpha Trial and a white paper on health value.

0 investors

SYFS Intermediate Holdings

0 investors

Sylke

0 investors

SymbioCellTech

SymbioCellTech develops a cell therapy called "Neo-Islets" intended to treat Type 1 Diabetes without daily insulin injections or immunosuppressive anti-rejection drugs. The company targets the estimated 16 million people living with Type 1 Diabetes.

0 investors

SymKardia

SymKardia develops a selective cardiac neuromodulation therapy to treat cardiac arrhythmias such as atrial fibrillation, targeting the nervous system rather than only cardiac tissue. It is a clinical-stage cardiovascular medical device company running pre-clinical and clinical research programs.

0 investors

Symplast Acquisition

0 investors

Synagile

0 investors

Synapse Health

Synapse Health manages the operational, administrative, and financial complexity of durable medical equipment (DME) for patients, prescribers, DME providers, and health plans. Through its InHome, Equip, and Patient Portal products, it coordinates DME intake, documentation, fulfillment, and support across the US, including for skilled nursing facilities and hospice.

0 investors

Sync-Think

0 investors

Synchronous Health

0 investors

Syncromune

Syncromune develops SYNC-T, an investigational in situ personalized combination immunotherapy platform designed to treat metastatic solid tumors by synchronizing patient-specific tumor antigens with immune modulatory biologics. The company's lead candidate, SV-102, is in Phase 2 clinical trials for metastatic castration-resistant prostate cancer.

0 investors

Synedgen

Synedgen develops first-in-class glycomics-based regenerative therapeutics that repair mucosal injury and restore barrier function. Its lead asset, MIIST305, is an orally delivered therapeutic that repairs gastrointestinal mucosal injury and reduces inflammation.

0 investors

Synereca Pharmaceuticals

0 investors

SynerFuse

SynerFuse is a Minnesota-based medical device company developing a spinal fusion procedure combined with direct nerve stimulation to treat chronic low back and leg pain. The company's patented e-TLIF procedure integrates spinal fusion with neuromodulation as a single implant solution.

0 investors

Synergeyes

SynergEyes designs and manufactures specialty hybrid and scleral contact lenses, including products for astigmatism, presbyopia, and irregular corneas such as keratoconus. It serves eye care patients and practitioners in the specialty contact lens market.

0 investors

Synergy MED Global Design Solutions

Synergy MedSolutions is a healthcare-focused organization operating through executive and joint venture teams, including a partnership with Woodmore Health Group. The page lists leadership roles but does not describe a specific product or service.

0 investors

Synergy Surgicenter

0 investors

SynerZ Medical

0 investors

Synovation Holdings

0 investors

Syntheon 2.0

0 investors

Synthonics

Synthonics develops Metal Coordination Pharmaceuticals (MCPs), which chelate metal ions to known drugs to improve properties such as absorption, efficacy, and onset of action. The company holds four US patents for its MCP technologies and works in the pharmaceutical and biotech industry.

0 investors

Syntilla Medical

0 investors

Syntr Health Technologies

Syntr Health Technologies makes the SyntrFuge System, an FDA-cleared device that automates the processing of autologous fat (microfat) for fat grafting, body contouring, and tissue healing. The device is aimed at clinical practicesβ€”including plastic, orthopedic, wound care, gastrointestinal, and veterinary surgeonsβ€”enabling in-office fat transfer procedures.

0 investors

Synvitrobio, Inc.

0 investors

Other sectors & tags

Healthtech Startups β€” Page 692 | Fundraising Fox